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Abstract
Background: Extragonadal localization of germ cell tumors (GCTs) is rare; to the best of our knowledge, a location
in the soft tissue of the arm has never been previously reported in the literature.
Case presentation: We report the case of a 37-year-old man who presented with a primary malignant mixed
non-seminomatous GCT (teratocarcinoma variety) in the right arm, treated by a combination of cisplatin-based
chemotherapy and surgery. After 18 months of close follow-up, no locoregional recurrence or distant metastases
have been detected.
Conclusions: A combination of chemotherapy and surgery is the most appropriate treatment strategy for
extragonadal GCTs, to ensure both local and systemic control.
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Background
Germ cell tumors (GCTs) are classified as extragonadal if
there is no evidence of a primary tumor in either the tes-
tes or ovaries [1]; they typically arise in midline locations.
In adults, the most common sites, in order of frequency,
are the anterior mediastinum, retroperitoneum, and the
pineal and suprasellar regions. To date, there have been
no reported cases of germ cell tumors arising in the arm.
The aim of the present work was not only to report
what is to the best of our knowledge the first observation
of a mixed non-seminomatous GCT of the arm, but to
also increase exposure of the various hypotheses that
could explain this unusual location. We also discuss the
diagnosis, treatment, and prognosis of this entity.
Case presentation
A 37-year-old man presented with a 2-year history of
painless swelling of the right arm with a gradual increase
in size. A physical examination was normal except for a
well circumscribed non-tender mass in the upper two-
thirds of the right arm and multiple lymph nodes in the
right axilla. Imaging revealed a 53 × 40 mm diameter soft
tissue mass that was hyperintense on T2-weighted MRI
in the posterior compartment of the right arm, with no
bone or vascular invasion (Figures 1 and 2). Surgical bi-
opsy of the mass and axillary lymph node excision were
performed; the laboratory received two fragments with soft
consistency, measuring 2× 1× 0.3 cm and 2.5 × 1× 0.5 cm.
Histopathological examination showed a desembryoplastic
multitissular tumor, containing a sarcomatous component
constituted by spindle cells and organized in bundles with
rhabdomyoblastic differentiation. There was also an im-
mature and malignant neuroglial component, and this
tumor additionally showed epithelial structures with squa-
mous or glandular differentiation; some cells were com-
patible with embryonal carcinoma. These various tissular
structures were very confluent, without transition. Atypical
immature cartilage and bone components were observed
associated with necrosis. The axillary lymph node excised
was metastatic. There was no need for immunohistochem-
ical staining to confirm the diagnosis of malignant mixed
GCT (teratocarcinoma variety) (Figure 3). Testicular pal-
pation and ultrasonography results were normal. A com-
puted tomography (CT) scan of the chest, abdomen and
pelvis showed no abnormalities. Serum α-fetoprotein
(AFP), β-human chorionic gonadotropin (β-HCG), and
serum lactate dehydrogenase (LDH) levels were all within
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normal ranges. The patient received four courses of
chemotherapy (bleomycin 30 units intravenous injection,
days 1, 8, and 15; etoposide 100 mg/m2 intravenously, days
1 through 5; cisplatin 20 mg/m2 intravenously, days 1
through 5). A clinical evaluation of response at the end of
chemotherapy showed a stable disease. Then, 1 month later,
a wide excision with axillary dissection was performed; the
excised tumor was partially well circumscribed and mea-
sured 57×42×38 mm and had a uniform, yellowish, solid,
and partially nodular appearance on the cut surface. Final
pathology revealed the same histological aspect as observed
in the biopsy but did not revealed tumoral necrotic pat-
terns. All surgical margins were free, and one of six lymph
nodes identified was involved without extracapsular spread
(Figures 4 and 5). Two further cycles of chemotherapy
using the same protocol were added. At 18 months of close
follow-up, no locoregional recurrence or distant metastases
have been detected.
Discussion
Primary GCTs of extragonadal origin comprise 3% to 5%
of all germ cell tumors. Extragonadal GCTs arise from
midline structures [2,3]. A case of extragonadal malig-
nant teratoma of the extremities has been reported by
Chinoy et al. [4]. Herein, we describe what is to the best of
our knowledge the first reported case of a mixed non-
seminomatous germ cell tumor (teratocarcinoma) located
in the soft tissue of the right arm. The histogenesis of
extragonadal GCTs is not clearly defined: two competing
hypotheses have been proposed, but there are inadequate
data to determine which, if either, is correct. The first
hypothesis is that extragonadal GCTs are derived from
primordial germ cells that fail to complete the normal mi-
gration along the urogenital ridge to the gonadal ridges
during embryonal development. This may be due to an ab-
normality in the primordial germ cell itself or in its micro-
environment [5]. The second main hypothesis is that germ
cells transformed in the testes undergo reverse migration
[6]. This hypothesis is supported by genetic data suggesting
that extragonadal GCTs and testicular GCTs share a com-
mon cell of origin [7,8]. The etiology of extragonadal GCTs
is unknown; in rare cases, they have been associated with
Klinefelter syndrome [9-12]. A biopsy is required for defini-
tive diagnosis and treatment of extragonadal GCTs; the
Figure 1 MRI image after administration of
gadolinium-diethylenetriaminepentacetate (Gd-DTPA) axial
showing a 53× 40 mm diameter soft tissue mass in the
posterior compartment of the right arm.
Figure 2 MRI image after administration of
gadolinium-diethylenetriaminepentacetate (Gd-DTPA) (coronal)
showing a 53× 40 mm diameter soft tissue mass in the
posterior compartment of the right arm.
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majority of patients have clear evidence of germ cell fea-
tures or teratoma, while a small subset have a poorly differ-
entiated tumor without distinctive germ cell features. In
our patient’s case the diagnosis of teratocarcinoma was
established on the basis of pathological examination, which
showed the combination of teratoma and embryonal car-
cinoma [13]. However it is important to note that the term
teratocarcinoma has largely been abandoned, and these
tumors are referred to as a malignant mixed GCT, with a
description of the specific germ cell tumor elements
present. Once the diagnosis of a germ cell tumor has been
established, a primary testicular tumor must be excluded.
Testicular palpation is insufficient to exclude a testicular
primary; ultrasonography should be performed in all
patients [14]. It may be difficult to distinguish true
extragonadal GCTs from metastatic tumors in which the
primary testicular lesion has regressed [15-17]. Extragonadal
non-seminomatous GCT should be considered in the differ-
ential diagnosis of histologically poorly differentiated cancer
and of neoplasms of unknown primary site, particularly in
young men with midline disease. In our patient’s case an-
other uncommon differential diagnosis must be evocated: it
is a soft tissue metastasis from primary testicular cancer
[18].
Because an extragonadal GCT may be curable with
cisplatin-based chemotherapy, many recommend that
the diagnostic evaluation in such cases should include
measurement of the serum tumor markers AFP and β-
HCG, immunohistochemical assessment of the biopsy [19],
and cytogenetic analysis for abnormalities of chromosome
arm 12p [20]. However, isochromosome 12p is not pathog-
nomonic of GCTs [21,22]. Mixed GCTs, mainly teratomas
with additional malignant components (other germ cell
tumors, carcinomas or sarcomas), have been reported to be
more aggressive. More than 50% of those patients died
within 2 years of follow-up due to local invasion or distant
metastases (lymph nodes, liver, lung, heart, bone, and
brain) [23,24]. A multimodality approach is generally used,
utilizing chemotherapy initially followed by surgery for any
residual mass. We recommend four cycles of bleomycin,
etoposide and cisplatin (BEP) chemotherapy as the ini-
tial therapy, rather than surgery or radiation therapy; for
patients with a residual mass following initial chemo-
therapy, we recommend complete surgical resection if
technically feasible. If viable malignancy is identified,
two additional cycles of chemotherapy should be given
[25,26].
Conclusions
Regardless of the location, the therapeutic approach of
extragonadal GCTs should be multidisciplinary, combining
systemic chemotherapy and surgery.
The decision of the number and timing of cycles of
chemotherapy depends on the disease stage and histo-
logical analysis of the surgical specimen.
Figure 4 Macroscopic aspect.
Figure 3 Different epithelial structures associated to
sarcomatous component (hematoxylin and eosin stain, 40 ×).
Figure 5 Tumor bed.
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